Literature DB >> 15999990

Probing the subpockets of factor Xa reveals two binding modes for inhibitors based on a 2-carboxyindole scaffold: a study combining structure-activity relationship and X-ray crystallography.

Marc Nazaré1, David W Will, Hans Matter, Herman Schreuder, Kurt Ritter, Matthias Urmann, Melanie Essrich, Armin Bauer, Michael Wagner, Jörg Czech, Martin Lorenz, Volker Laux, Volkmar Wehner.   

Abstract

Structure-activity relationships within a series of highly potent 2-carboxyindole-based factor Xa inhibitors incorporating a neutral P1 ligand are described with particular emphasis on the structural requirements for addressing subpockets of the factor Xa enzyme. Interactions with the subpockets were probed by systematic substitution of the 2-carboxyindole scaffold, in combination with privileged P1 and P4 substituents. Combining the most favorable substituents at the indole nucleus led to the discovery of a remarkably potent factor Xa inhibitor displaying a K(i) value of 0.07 nM. X-ray crystallography of inhibitors bound to factor Xa revealed substituent-dependent switching of the inhibitor binding mode and provided a rationale for the SAR obtained. These results underscore the key role played by the P1 ligand not only in determining the binding affinity of the inhibitor by direct interaction but also in modifying the binding mode of the whole scaffold, resulting in a nonlinear SAR.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999990     DOI: 10.1021/jm0490540

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  21 in total

Review 1.  The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor.

Authors:  Elisabeth Perzborn; Susanne Roehrig; Alexander Straub; Dagmar Kubitza; Frank Misselwitz
Journal:  Nat Rev Drug Discov       Date:  2010-12-17       Impact factor: 84.694

2.  Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold.

Authors:  Rami A Al-Horani; Akul Y Mehta; Umesh R Desai
Journal:  Eur J Med Chem       Date:  2012-06-23       Impact factor: 6.514

3.  Role of the active-site solvent in the thermodynamics of factor Xa ligand binding.

Authors:  Robert Abel; Tom Young; Ramy Farid; Bruce J Berne; Richard A Friesner
Journal:  J Am Chem Soc       Date:  2008-02-12       Impact factor: 15.419

4.  Cl-pi interactions in protein-ligand complexes.

Authors:  Yumi N Imai; Yoshihisa Inoue; Isao Nakanishi; Kazuo Kitaura
Journal:  Protein Sci       Date:  2008-04-23       Impact factor: 6.725

5.  How much binding affinity can be gained by filling a cavity?

Authors:  Yuko Kawasaki; Eduardo E Chufan; Virginie Lafont; Koushi Hidaka; Yoshiaki Kiso; L Mario Amzel; Ernesto Freire
Journal:  Chem Biol Drug Des       Date:  2009-12-17       Impact factor: 2.817

6.  3D proteochemometrics: using three-dimensional information of proteins and ligands to address aspects of the selectivity of serine proteases.

Authors:  Vigneshwari Subramanian; Qurrat Ul Ain; Helena Henno; Lars-Olof Pietilä; Julian E Fuchs; Peteris Prusis; Andreas Bender; Gerd Wohlfahrt
Journal:  Medchemcomm       Date:  2017-03-15       Impact factor: 3.597

7.  Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.

Authors:  Feng Liu; Dalia Barsyte-Lovejoy; Abdellah Allali-Hassani; Yunlong He; J Martin Herold; Xin Chen; Christopher M Yates; Stephen V Frye; Peter J Brown; Jing Huang; Masoud Vedadi; Cheryl H Arrowsmith; Jian Jin
Journal:  J Med Chem       Date:  2011-08-05       Impact factor: 7.446

8.  A molecular mechanics approach to modeling protein-ligand interactions: relative binding affinities in congeneric series.

Authors:  Chaya Rapp; Chakrapani Kalyanaraman; Aviva Schiffmiller; Esther Leah Schoenbrun; Matthew P Jacobson
Journal:  J Chem Inf Model       Date:  2011-08-09       Impact factor: 4.956

9.  Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.

Authors:  Feng Liu; Dalia Barsyte-Lovejoy; Fengling Li; Yan Xiong; Victoria Korboukh; Xi-Ping Huang; Abdellah Allali-Hassani; William P Janzen; Bryan L Roth; Stephen V Frye; Cheryl H Arrowsmith; Peter J Brown; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2013-10-31       Impact factor: 7.446

10.  Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach.

Authors:  E Prabhu Raman; Wenbo Yu; Sirish K Lakkaraju; Alexander D MacKerell
Journal:  J Chem Inf Model       Date:  2013-11-25       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.